A Study to Assess the Efficacy of a 5-day, 10- mg PBF-680 Oral Administration on Late Asthmatic Responses (LAR) in Mild to Moderate Asthmatic Patients.
Clinical trial NCT02635945 · COMPLETED
Trial details
- NCT number
- NCT02635945
- Sponsor
- Palobiofarma SL
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2019-09-30
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.